PT1989323E - Métodos de diagnóstico envolvendo a determinação do número de cópias de genes e snps no grupo de genes fcrii/fcriii e sondas para usar em tais métodos para detecção da susceptibilidade a doenças auto-imunes e eficácia do correspondent - Google Patents

Métodos de diagnóstico envolvendo a determinação do número de cópias de genes e snps no grupo de genes fcrii/fcriii e sondas para usar em tais métodos para detecção da susceptibilidade a doenças auto-imunes e eficácia do correspondent Download PDF

Info

Publication number
PT1989323E
PT1989323E PT06835684T PT06835684T PT1989323E PT 1989323 E PT1989323 E PT 1989323E PT 06835684 T PT06835684 T PT 06835684T PT 06835684 T PT06835684 T PT 06835684T PT 1989323 E PT1989323 E PT 1989323E
Authority
PT
Portugal
Prior art keywords
amount
subject
rii
snps
probes
Prior art date
Application number
PT06835684T
Other languages
English (en)
Inventor
Dirk Roos
Taco Willem Kuijpers
Original Assignee
Sanquin Bloedvoorziening
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanquin Bloedvoorziening filed Critical Sanquin Bloedvoorziening
Publication of PT1989323E publication Critical patent/PT1989323E/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844Nucleic acid amplification reactions
    • C12Q1/6851Quantitative amplification
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/156Polymorphic or mutational markers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/172Haplotypes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
PT06835684T 2005-12-22 2006-12-22 Métodos de diagnóstico envolvendo a determinação do número de cópias de genes e snps no grupo de genes fcrii/fcriii e sondas para usar em tais métodos para detecção da susceptibilidade a doenças auto-imunes e eficácia do correspondent PT1989323E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP05077984A EP1801234A1 (en) 2005-12-22 2005-12-22 Diagnostic methods involving determining gene copy numbers and use thereof

Publications (1)

Publication Number Publication Date
PT1989323E true PT1989323E (pt) 2011-09-29

Family

ID=35953866

Family Applications (1)

Application Number Title Priority Date Filing Date
PT06835684T PT1989323E (pt) 2005-12-22 2006-12-22 Métodos de diagnóstico envolvendo a determinação do número de cópias de genes e snps no grupo de genes fcrii/fcriii e sondas para usar em tais métodos para detecção da susceptibilidade a doenças auto-imunes e eficácia do correspondent

Country Status (10)

Country Link
US (2) US7994300B2 (pt)
EP (2) EP1801234A1 (pt)
AT (1) ATE515580T1 (pt)
AU (1) AU2006327982A1 (pt)
CA (1) CA2634692A1 (pt)
DK (1) DK1989323T3 (pt)
ES (1) ES2369415T3 (pt)
PL (1) PL1989323T3 (pt)
PT (1) PT1989323E (pt)
WO (1) WO2007073179A2 (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009048027A1 (ja) 2007-10-09 2009-04-16 Arkray, Inc. 免疫関連遺伝子の多型の検出用プローブおよびその用途
EP2055790A1 (en) * 2007-10-30 2009-05-06 Leibniz-Institut für Altersforschung - Fritz-Lipmann-Institut e.V. Calibration molecule and method for determining the number of copies of genes/target loci in a genome using said calibration molecule
WO2009062080A1 (en) * 2007-11-08 2009-05-14 Pikamab, Inc. Methods for doing business using biomarkers
CA2711483A1 (en) * 2008-01-09 2009-07-16 Octapharma Ag Assay and method for the assessment of responders and non-responders to nk cell modulation by immunoglobulin therapy
CA2749215A1 (en) * 2009-01-08 2010-07-15 The Uab Research Foudation Process for regulating immune response
CA2789168A1 (en) * 2010-02-02 2011-08-11 Abbott Biotechnology Ltd. Methods and compositions for predicting responsiveness to treatment with tnf-.alpha. inhibitor
US20140336950A1 (en) * 2011-11-16 2014-11-13 Univerisity of South Dakota Clustering copy-number values for segments of genomic data

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5830652A (en) 1994-08-30 1998-11-03 New York Society For The Ruptured And Crippled Maintaining The Hospital For Special Surgery Method for determining predisposition to severe forms of autoimmune disease by determining Fcy receptor allelic patterns
US6905827B2 (en) * 2001-06-08 2005-06-14 Expression Diagnostics, Inc. Methods and compositions for diagnosing or monitoring auto immune and chronic inflammatory diseases
EP1511690A4 (en) * 2002-05-16 2007-10-24 Univ Vanderbilt TECHNIQUE FOR PREDICTING AUTOIMMUNE DISEASES
ATE536188T1 (de) * 2002-08-14 2011-12-15 Macrogenics Inc Fcgammariib-spezifische antikörper und verfahren zur verwendung davon
US20080248465A1 (en) 2004-04-26 2008-10-09 Uab Research Foundation Polymorphisms in the Fcgr2b Promoter and Uses Thereof

Also Published As

Publication number Publication date
PL1989323T3 (pl) 2011-12-30
ES2369415T3 (es) 2011-11-30
AU2006327982A1 (en) 2007-06-28
CA2634692A1 (en) 2007-06-28
EP1989323A2 (en) 2008-11-12
US20090263795A1 (en) 2009-10-22
WO2007073179A2 (en) 2007-06-28
AU2006327982A8 (en) 2008-07-24
ATE515580T1 (de) 2011-07-15
DK1989323T3 (da) 2011-09-26
US20110189672A1 (en) 2011-08-04
WO2007073179A3 (en) 2008-01-17
US8765372B2 (en) 2014-07-01
US7994300B2 (en) 2011-08-09
EP1989323B1 (en) 2011-07-06
EP1801234A1 (en) 2007-06-27

Similar Documents

Publication Publication Date Title
PT1989323E (pt) Métodos de diagnóstico envolvendo a determinação do número de cópias de genes e snps no grupo de genes fcrii/fcriii e sondas para usar em tais métodos para detecção da susceptibilidade a doenças auto-imunes e eficácia do correspondent
AU2017339858B2 (en) Improved methods of assessing GFAP status in patient samples
JP7277623B2 (ja) 生体試料中で改善された性能を有するigfbp7のためのアッセイ
JP5709341B2 (ja) 個体の再構成又は標的遺伝的組換えの定量的評価の方法及びその使用
CA3067055A1 (en) Methods for aiding in diagnosing and evaluating a traumatic brain injury in a human subject using a combination of gfap and uch-l1
Recke et al. Pathogenicity of IgG subclass autoantibodies to type VII collagen: Induction of dermal–epidermal separation
CA2778810C (en) Assays for detecting antibodies specific to therapeutic anti-ige antibodies and their use in anaphylaxis
JP7054990B2 (ja) 炎症性腸疾患の診断及び治療のための方法
JP2015535820A5 (pt)
CN103608038A (zh) 施用β7整联蛋白拮抗剂的方法
MX2015003932A (es) Metodos para diagnosticar y tratar la enfermedad inflamatoria intestinal.
EP1910836A2 (en) Potency assays for antibody drug substance binding to an fc receptor
CN112469434A (zh) 抗pla2-gib抗体及其用途
US20070231813A1 (en) Fcgr3a Gebotype and Methods for Evaluating Treatment Response to Non-Depleting Antibodies
SG187787A1 (en) Dual function in vitro target binding assay for the detection of neutralizing antibodies against target antibodies
JP2022528804A (ja) 抗体力価試験
JP2008500832A (ja) Fcgr3aゲボタイプ(gebotype)および非枯渇性抗体に対する処置応答を評価するための方法
CN109963865A (zh) 用于检测和治疗肥大细胞活性相关病症的生物标记
Aoyama et al. A cell-based reporter assay measuring the activation of fc gamma receptors induced by therapeutic monoclonal antibodies
JPWO2009133951A1 (ja) 抗汗抗原モノクローナル抗体
Sethi et al. VH1 family immunoglobulin repertoire sequencing after allogeneic hematopoietic stem cell transplantation
Wang et al. Generation and characterization of a unique reagent that recognizes a panel of recombinant human monoclonal antibody therapeutics in the presence of endogenous human IgG
CA2440960A1 (en) An early pre-symptomatic prion diagnostic blood test for encephalopathies
JP2023553890A (ja) 疾患関連タンパク質組成物を産生するためのシステム及び方法
CN108139385A (zh) 用于诊断和治疗炎症性肠病的方法